Avivagen Inc. | Income Statement
Fiscal year is November-October. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
110.50
295.70
164.00
10.60
255.70
1,072.60
Cost of Goods Sold (COGS) incl. D&A
72.50
88.70
21.90
14.20
83.20
421.40
Gross Income
38.00
207.00
142.00
3.60
172.50
651.20
SG&A Expense
2,662.70
2,302.70
2,141.00
2,582.10
4,984.60
4,974.30
EBIT
2,624.70
2,095.70
1,999.00
-
4,812.20
4,323.10
Unusual Expense
471.80
-
-
-
-
250
Non Operating Income/Expense
128.90
15.30
5.00
-
-
-
Interest Expense
-
-
-
203.90
233.50
435.10
Pretax Income
2,024.00
2,080.40
2,004.00
2,742.60
5,045.60
5,008.20
Consolidated Net Income
2,024.00
2,080.40
2,004.00
2,742.60
5,045.60
4,834.10
Net Income
2,024.00
2,080.40
2,004.00
2,742.60
5,045.60
4,834.10
Net Income After Extraordinaries
2,024.00
2,080.40
2,004.00
2,741.20
4,955.60
4,834.10
Net Income Available to Common
2,024.00
2,080.40
2,004.00
2,744.00
5,135.70
4,834.10
EPS (Basic)
0.18
0.12
0.10
1.23
0.18
0.15
Basic Shares Outstanding
11,307.40
16,900.80
19,341.90
2,235.70
29,026.30
33,058
EPS (Diluted)
0.18
0.12
0.10
1.23
0.18
0.15
Diluted Shares Outstanding
11,307.40
16,900.80
19,341.90
2,235.70
29,026.30
33,058
EBITDA
2,556.50
2,062.60
1,978.10
2,574.00
4,812.20
4,320.50
About Avivagen
View Profile
